PT Kalbe Farma Tbk. (IDX:KLBF)

Market Cap	44.64T -26.7%
Revenue (ttm)	34.38T +7.0%
Net Income	3.49T +13.4%
EPS	76.64 +14.7%
Shares Out	45.32B
PE Ratio	12.85
Forward PE	12.12
Dividend	36.00 (3.65%)
Ex-Dividend Date	Jun 4, 2025

Volume	55,949,700
Average Volume	51,784,000
Open	990.00
Previous Close	970.00
Day's Range	985.00 - 1,020.00
52-Week Range	960.00 - 1,600.00
Beta	-0.00
RSI	36.54
Earnings Date	Mar 27, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pro...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,784
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.